Veronorte S.A.S. is a global venture capital fund investing in early-stage companies.
Location
Medellín, Antioquia Department, CO
Founded
2012
Veronorte is a global venture capital fund focusing on early-stage companies. While specific investment sizes are not disclosed, their portfolio suggests a range from seed to later-stage rounds. The firm's investment strategy appears to span various sectors, including healthtech, foodtech, and insurtech.
Notable portfolio companies include Clover Health, a Medicare Advantage insurance company, and Shiru, a company developing protein ingredients through computational design. Veronorte's investments in companies like Alkanza, Slice Labs, and Welltok further demonstrate their interest in innovative technologies across different industries. The firm likely provides strategic support and resources to help their portfolio companies scale and succeed.
Veronorte - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies9
Current Portfolio Count9
Top Investment Stages
Series A4 (44.4%)
Series C2 (22.2%)
Series B1 (11.1%)
Series D1 (11.1%)
Series E1 (11.1%)
Stage Mix
Series A 44%Series C 22%Series B 11%Series D 11%Series E 11%
Concentration shown as share of disclosed investments by stage.